Mary K. Ritke

Mutational inactivation of the p53 gene in the human erythroid leukemic K562 cell line

John C. Law, Mary K. Ritke, Jack C. Yalowich et al. · Leukemia Research · 1993 · 162 citations

Hematological Malignancy, Pathology, Cell Death +7

Altered gene expression in human leukemia K562 cells selected for resistance to etoposide

Mary K. Ritke, Jack C. Yalowich · Biochemical Pharmacology · 1993 · 51 citations

Hematological Malignancy, Cell Regulation, Mixed-phenotype Acute Leukemia +9

Increased c-jun/AP-1 levels in etoposide-resistant human leukemia K562 cells

Mary K. Ritke, Vladimir V. Bergoltz, William P. Allan et al. · Biochemical Pharmacology · 1994 · 34 citations

Hematological Malignancy, Cancer Research, C-jun/ap-1 Levels +7

Alternative RNA Processing of Topoisomerase IIα in Etoposide-Resistant Human Leukemia K562 Cells: Intron Retention Results in a Novel C-Terminal Truncated 90-kDa Isoform

Ragu Kanagasabai, Lucas D. Serdar, Soumendrakrishna Karmahapatra et al. · Journal of Pharmacology and Experimental Therapeutics · 2016 · 20 citations